Literature DB >> 18237196

Steady-state and pre-steady-state kinetic evaluation of severe acute respiratory syndrome coronavirus (SARS-CoV) 3CLpro cysteine protease: development of an ion-pair model for catalysis.

James Solowiej1, James A Thomson, Kevin Ryan, Chun Luo, Mingying He, Jihong Lou, Brion W Murray.   

Abstract

Severe acute respiratory syndrome (SARS) was a worldwide epidemic caused by a coronavirus that has a cysteine protease (3CLpro) essential to its life cycle. Steady-state and pre-steady-state kinetic methods were used with highly active 3CLpro to characterize the reaction mechanism. We show that 3CLpro has mechanistic features common and disparate to the archetypical proteases papain and chymotrypsin. The kinetic mechanism for 3CLpro-mediated ester hydrolysis, including the individual rate constants, is consistent with a simple double displacement mechanism. The pre-steady-state burst rate was independent of ester substrate concentration indicating a high commitment to catalysis. When homologous peptidic amide and ester substrates were compared, a series of interesting observations emerged. Despite a 2000-fold difference in nonenzymatic reactivity, highly related amide and ester substrates were found to have similar kinetic parameters in both the steady-state and pre-steady-state. Steady-state solvent isotope effect (SIE) studies showed an inverse SIE for the amide but not ester substrates. Evaluation of the SIE in the pre-steady-state revealed normal SIEs for both amide and ester burst rates. Proton inventory (PI) studies on amide peptide hydrolysis were consistent with two proton-transfer reactions in the transition state while the ester data was consistent with a single proton-transfer reaction. Finally, the pH-inactivation profile of 3CLpro with iodoacetamide is indicative of an ion-pair mechanism. Taken together, the data are consistent with a 3CLpro mechanism that utilizes an "electrostatic" trigger to initiate the acylation reaction, a cysteine-histidine catalytic dyad ion pair, an enzyme-facilitated release of P1, and a general base-catalyzed deacylation reaction.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18237196     DOI: 10.1021/bi702107v

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  9 in total

1.  Mutation of Glu-166 blocks the substrate-induced dimerization of SARS coronavirus main protease.

Authors:  Shu-Chun Cheng; Gu-Gang Chang; Chi-Yuan Chou
Journal:  Biophys J       Date:  2010-04-07       Impact factor: 4.033

2.  Discovery of Ketone-Based Covalent Inhibitors of Coronavirus 3CL Proteases for the Potential Therapeutic Treatment of COVID-19.

Authors:  Robert L Hoffman; Robert S Kania; Mary A Brothers; Jay F Davies; Rose A Ferre; Ketan S Gajiwala; Mingying He; Robert J Hogan; Kirk Kozminski; Lilian Y Li; Jonathan W Lockner; Jihong Lou; Michelle T Marra; Lennert J Mitchell; Brion W Murray; James A Nieman; Stephen Noell; Simon P Planken; Thomas Rowe; Kevin Ryan; George J Smith; James E Solowiej; Claire M Steppan; Barbara Taggart
Journal:  J Med Chem       Date:  2020-10-15       Impact factor: 7.446

3.  In silico studies of selected multi-drug targeting against 3CLpro and nsp12 RNA-dependent RNA-polymerase proteins of SARS-CoV-2 and SARS-CoV.

Authors:  Inemesit A Udofia; Kofoworola O Gbayo; Oluwakemi A Oloba-Whenu; Taofeek B Ogunbayo; Chukwuemeka Isanbor
Journal:  Netw Model Anal Health Inform Bioinform       Date:  2021-03-25

4.  What would Sérgio Ferreira say to your physician in this war against COVID-19: How about kallikrein/kinin system?

Authors:  Lucas A D Nicolau; Pedro J C Magalhães; Mariana L Vale
Journal:  Med Hypotheses       Date:  2020-05-30       Impact factor: 1.538

5.  Probing the Dynamic Structure-Function and Structure-Free Energy Relationships of the Coronavirus Main Protease with Biodynamics Theory.

Authors:  Hongbin Wan; Vibhas Aravamuthan; Robert A Pearlstein
Journal:  ACS Pharmacol Transl Sci       Date:  2020-11-06

Review 6.  What coronavirus 3C-like protease tells us: From structure, substrate selectivity, to inhibitor design.

Authors:  Muya Xiong; Haixia Su; Wenfeng Zhao; Hang Xie; Qiang Shao; Yechun Xu
Journal:  Med Res Rev       Date:  2021-01-18       Impact factor: 12.388

Review 7.  SARS-CoV-2 involvement in central nervous system tissue damage.

Authors:  Muhammad Ali Haidar; Zaynab Shakkour; Mohammad Amine Reslan; Nadine Al-Haj; Perla Chamoun; Karl Habashy; Hasan Kaafarani; Shima Shahjouei; Sarah H Farran; Abdullah Shaito; Esber S Saba; Bassam Badran; Mirna Sabra; Firas Kobeissy; Maya Bizri
Journal:  Neural Regen Res       Date:  2022-06       Impact factor: 5.135

8.  New insights into the catalytic mechanism of the SARS-CoV-2 main protease: an ONIOM QM/MM approach.

Authors:  Henrique S Fernandes; Sérgio F Sousa; Nuno M F S A Cerqueira
Journal:  Mol Divers       Date:  2021-06-24       Impact factor: 3.364

9.  Inhibition Mechanism of SARS-CoV-2 Main Protease with Ketone-Based Inhibitors Unveiled by Multiscale Simulations: Insights for Improved Designs*.

Authors:  Carlos A Ramos-Guzmán; J Javier Ruiz-Pernía; Iñaki Tuñón
Journal:  Angew Chem Int Ed Engl       Date:  2021-11-03       Impact factor: 15.336

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.